Select Medical (SEM) Fundamental Analysis: Revenue, Earnings & Valuation

3.86 / 10

Netural

Fundamental analysis rates SEM neutral (3.9/10). Positive factors include PB‑ROE and operating cash‑flow growth, yet Revenue‑MV, basic and diluted EPS YoY declines, and asset‑MV lag. Overall, the company shows weak fundamentals, urging prudence.

Analysis Checks(2/10)

Revenue-MV

Value1.73

Score1/3

Weight54.00%

1M Return3.16%

Net cash flow from operating activities per share (YoY growth rate %)

Value-30.43

Score1/3

Weight13.55%

1M Return0.81%

PB-ROE

Value-0.74

Score2/3

Weight13.96%

1M Return0.81%

Basic earnings per share (YoY growth rate %)

Value-30.12

Score0/3

Weight-23.52%

1M Return-1.82%

Total profit (YoY growth rate %)

Value56.06

Score1/3

Weight23.63%

1M Return1.41%

Net cash flow from operating activities (YoY growth rate %)

Value-33.10

Score2/3

Weight26.28%

1M Return1.55%

Cash-UP

Value-1.15

Score1/3

Weight10.75%

1M Return0.66%

Diluted earnings per share (YoY growth rate %)

Value-30.12

Score0/3

Weight-22.57%

1M Return-1.72%

Asset-MV

Value-0.55

Score1/3

Weight26.09%

1M Return1.77%

Cash-MV

Value0.11

Score0/3

Weight-22.16%

1M Return-1.72%

Is SEM undervalued or overvalued?

SEM scores 3.86/10 on fundamentals and holds a Fair valuation at present. Backed by its 7.25% ROE, 3.93% net margin, 13.82 P/E ratio, 0.99 P/B ratio, and -30.12% earnings growth, these metrics solidify its Netural investment rating.